Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 355 participants.
Also called NCT07582835
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 355 participants
- Sponsor
- Cardiocentro Ticino
- Registry
-
NCT07582835
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT07582835. Randomized; no masking; primary purpose treatment. Start 2026-04-20 (anticipated); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
- Acronym
- HI-TECH 2
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Condition
- Acute Coronary Syndromes
- Condition
- Antiplatelet Therapy
- Condition
- Single Antiplatelet Therapy
- Condition
- Coagulation Factors
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Prasugrel
- Lead sponsor
- Cardiocentro Ticino
Record details
- Record id
cardio:ct-nct07582835- Content hash
854df28a804cde19f9cb96d6fcfcc60bdd32f054f73bc048503e4f672c9a9132